[1] Department of National Health and Welfare and the Department of Advisory Committee on Mutagenesis. Guidelines on the use of mutagenicity tests in the toxicological evaluation of chemicals[J]. Environ Mol Mutagen, 1988, 11(2):261-304.
[2] WASSOM J S, MALLING H V, SANKARANARAYANAN K, et al. Reflections on the origins and evolution of genetic toxicology and the Environmental Mutagen Society[J]. Environ Mol Mutagen, 2010, 51(8/9):746-760.
[3] International Council on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Topic S2(R1) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use[S/OL].[2011-01-12]. https://www.ema.europa.eu/en/ich-s2-r1-genotoxicity-testing-data-interpretation-pharmaceuticals-intended-human-use.
[4] COMMITTEE E S. Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment[J]. EFSA J, 2011, 9(9):2379.
[5] 中华人民共和国国家卫生和计划生育委员会. GB 15193.1-2014食品安全国家标准食品安全性毒理学评价程序[S]. 北京:中国标准出版社, 2014.
[6] ELHAJOUJI A, VAN HUMMELEN P, KIRSCH-VOLDERS M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes[J]. Environ Mol Mutagen, 1995, 26(4):292-304.
[7] DOAK S H, JENKINS G J, JOHNSON G E, et al. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens[J]. Cancer Res, 2007, 67(8):3904-3911.
[8] JOHNSON G E, DOAK S H, GRIFFITHS S M, et al. Non-linear dose-response of DNA-reactive genotoxins:recommendations for data analysis[J]. Mutat Res, 2009, 678(2):95-100.
[9] GUÉRARD M, BAUM M, BITSCH A, et al. Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing[J]. Mutat Res Rev Mutat Res, 2015, 763:181-201.
[10] MACGREGOR J T, FRÖTSCHL R, WHITE P A, et al. IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs)[J]. Mutat Res Genet Toxicol Environ Mutagen, 2015, 783:55-65.
[11] GOLLAPUDI B B, JOHNSON G E, HERNANDEZ L G, et al. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies[J]. Environ Mol Mutagen, 2013, 54(1):8-18.
[12] MÜLLER L, GOCKE E, LAVÉ T, et al. Ethyl methanesulfonate toxicity in Viracept:a comprehensive human risk assessment based on threshold data for genotoxicity[J]. Toxicol Lett, 2009, 190(3):317-329.
[13] WALKER V E, CASCIANO D A, TWEATS D J. The Viracept-EMS case:Impact and outlook[J]. Toxicol Lett, 2009, 190(3):333-339.
[14] JOHNSON G E, SLOB W, DOAK S H, et al. New approaches to advance the use of genetic toxicology analyses for human health risk assessment[J]. Toxicol Res (Camb), 2015, 4(3):667-676.
[15] POTTENGER L H, GOLLAPUDI B B. Genotoxicity testing:moving beyond qualitative "screen and Bin" approach towards characterization of dose-response and thresholds[J]. Environ Mol Mutagen, 2010, 51(8/9):792-799.
[16] JOHNSON G E, SOETEMAN-HERNÁNDEZ L G, GOLLAPUDI B B, et al. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment[J]. Environ Mol Mutagen, 2014, 55(8):609-623.
[17] HOTHORN L A. Statistical evaluation of toxicological bioassays-A review[J]. Toxicol Res (Camb), 2014, 3(6):418-432.
[18] LUTZ W K, LUTZ R W. Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data[J]. Mutat Res, 2009, 678(2):118-122.
[19] Vito M R M. Segmented:An R package to Fit Regression Models with Broken-Line Relationships[J]. R News, 2008, 8(1):20-25.
[20] CRUMP K S. Use of threshold and mode of action in risk assessment[J]. Crit Rev Toxicol, 2011, 41(8):637-650.
[21] LUTZ W K, GAYLOR D W, CONOLLY R B, et al. Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility[J]. Toxicol Appl Pharmacol, 2005, 207(2 Suppl):565-569.
[22] HARDY A, BENFORD D, HALLDORSSON T, et al. Update:use of the benchmark dose approach in risk assessment[J]. EFSA J, 2016, 15(1):4658.
[23] EFSA Panel on Contaminants in the Food Chain. Update of the risk assessment on 3-monochloropropane diol and its fatty acid esters[J]. EFSA J, 2018, 16(1):5083.
[24] IZADI H, GRUNDY J E, BOSE R. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings[J]. Risk Anal, 2012, 32(5):830-835.
[25] ZELLER A, TANG L L, DERTINGER S D, et al. A proposal for a novel rationale for critical effect size in dose-response analysis based on a multi-endpoint in vivo study with methyl methanesulfonate[J]. Mutagenesis, 2016, 31(3):239-253.
[26] CAO X F, MITTELSTAEDT R A, PEARCE M G, et al. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice[J]. Environ Mol Mutagen, 2014, 55(5):385-399.
[27] SLOB W. Dose-response modeling of continuous endpoints[J]. Toxicol Sci, 2002, 66(2):298-312.
[28] DAVIS J A, GIFT J S, ZHAO Q J. Introduction to benchmark dose methods and US EPA's benchmark dose software (BMDS) version 2.1.1[J]. Toxicol Appl Pharmacol, 2011, 254(2):181-191.
[29] BARLOW S, RENWICK A G, KLEINER J, et al. Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe[J]. Food Chem Toxicol, 2006, 44(10):1636-1650.
[30] Health Canada. The assessment of mutagenicity health protection branch mutagenicity guidelines[J]. Environ Mol Mutagen, 1993, 21(1):15-37.
[31] MACGREGOR J T, FRÖTSCHL R, WHITE P A, et al. IWGT report on quantitative approaches to genotoxicity risk assessment Ⅱ. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk[J]. Mutat Res Genet Toxicol Environ Mutagen, 2015, 783:66-78.
[32] European Medicines Agency. European public assessment (EPAR) Viracept[R]. 2008.
[33] BLAKEY D, GALLOWAY S M, KIRKLAND D J, et al. Regulatory aspects of genotoxicity testing:from hazard identification to risk assessment[J]. Mutat Res, 2008, 657(1):84-90. |
